GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Neola Medical NEOLA.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

0.48

-0.83%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SEK, from our data supplier.

FY2025

Revenue

—

FY2016FY2025

Net income

−SEK 11.0m

FY2016FY2025

Free cash flow

−SEK 23.9m

FY2016FY2025

Shareholders' equity

SEK 75.8m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue————SEK 625,000SEK 31,000SEK 16,000SEK 575,000SEK 5.0mSEK 2.2m
Research and development——SEK 160,000SEK 200,000——————
Operating income−SEK 11.1m−SEK 11.1m−SEK 9.6m−SEK 10.4m−SEK 7.4m−SEK 7.9m−SEK 3.2m−SEK 1.3m−SEK 5.4m−SEK 3.8m
Net income−SEK 11.0m−SEK 10.1m−SEK 9.0m−SEK 10.4m−SEK 6.7m−SEK 6.7m−SEK 2.6m−SEK 761,000−SEK 5.1m−SEK 3.8m
Diluted earnings per share-0.14-0.14-0.16-0.25-0.37-0.09-0.03-0.01-0.38-0.28

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsSEK 78.8mSEK 73.6mSEK 86.0mSEK 75.3mSEK 43.8mSEK 26.0mSEK 12.2mSEK 14.0mSEK 19.3mSEK 20.5m
Cash and short-term investmentsSEK 16.1mSEK 19.6mSEK 21.6mSEK 40.1mSEK 22.9mSEK 16.6mSEK 5.4mSEK 9.9mSEK 8.4mSEK 11.0m
Total liabilitiesSEK 3.0mSEK 4.6mSEK 7.0mSEK 7.8mSEK 3.2mSEK 2.4mSEK 1.5mSEK 671,000SEK 5.0mSEK 3.7m
Shareholders' equitySEK 75.8mSEK 69.0mSEK 79.0mSEK 67.5mSEK 40.6mSEK 23.5mSEK 10.7mSEK 13.3mSEK 14.4mSEK 16.8m
Shares outstanding78m70m56m41m18m78m78m78m13m13m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−SEK 12.0m−SEK 10.8m−SEK 6.5m−SEK 8.5m−SEK 6.9m−SEK 6.1m−SEK 2.1m−SEK 1.3m−SEK 1.1m−SEK 4.4m
Capital spending−SEK 12.0m−SEK 11.2m−SEK 12.3m−SEK 11.6m−SEK 10.5m−SEK 2.2m−SEK 2.4m−SEK 1.4m——
Free cash flow−SEK 23.9m−SEK 22.0m−SEK 18.8m−SEK 20.1m−SEK 17.4m−SEK 8.3m−SEK 4.5m−SEK 2.7m−SEK 1.1m−SEK 4.4m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Operating income−SEK 3.7m−SEK 3.6m−SEK 2.5m−SEK 2.8m−SEK 3.0m−SEK 2.7m−SEK 2.7m−SEK 2.5m
Net income−SEK 3.7m−SEK 3.6m−SEK 2.7m−SEK 2.8m−SEK 3.0m−SEK 2.6m−SEK 2.6m−SEK 2.3m
Diluted earnings per share-0.05-0.05-0.03-0.04-0.04-0.03-0.04-0.03
Cash from operations−SEK 2.0m−SEK 3.0m−SEK 2.0m−SEK 2.0m−SEK 3.0m−SEK 2.0m−SEK 2.0m−SEK 5.0m
Capital spending——−SEK 2.0m−SEK 2.0m−SEK 3.0m—−SEK 2.0m−SEK 5.0m
Free cash flow——−SEK 4.0m−SEK 4.0m−SEK 6.0m—−SEK 4.0m−SEK 10.0m
Total assetsSEK 104.4mSEK 75.3mSEK 78.8mSEK 82.6mSEK 85.3mSEK 88.9mSEK 73.6mSEK 76.6m
Cash and short-term investmentsSEK 4.0mSEK 10.0mSEK 16.1mSEK 22.1mSEK 26.5mSEK 32.7mSEK 19.6mSEK 24.2m
Shareholders' equitySEK 97.6mSEK 72.2mSEK 75.8mSEK 78.5mSEK 81.2mSEK 84.2mSEK 69.0mSEK 71.6m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income2.3%7.2%—
Net income2.1%10.4%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020
Price to earnings-7.5-14.1-12.1-5.3-4.5-33.3
Price to sales————48.2—

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.